EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Digital Gait Outcomes for Autosomal Recessive Spastic Ataxia of Charlevoix‐Saguenay ( ARSACS) : Discriminative, Convergent, and Ecological Validity in a Multicenter Study ( PROSPAX )

Lukas Beichert iD, Winfried Ilg iD, Christoph Kessler, Andreas Traschütz iD, Selina Reich, Filippo M Santorelli, Ayşe Nazli Başak iD, Cynthia Gagnon iD, PROSPAX Consortium, Rebecca Schüle, Matthis Synofzik iD

Movement Disorders · 2024-09 · 39 (9) · 1544-1555

DOI: 10.1002/mds.29876 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Movement Disorders, online erschienen am 07.06.2024. Verfasst von Lukas Beichert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center for Neurology, University of T…. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias, Muscle Spasticity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Medizinischen Fakultät, Eberhard Karls Universität Tübingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With treatment trials on the horizon, this study aimed to identify candidate digital‐motor gait outcomes for autosomal recessive spastic ataxia of Charlevoix‐Saguenay (ARSACS), capturable by wearable sensors with multicenter validity, and ideally also ecological validity during free walking outside laboratory settings.

Methods

Cross‐sectional multicenter study (four centers), with gait assessments in 36 subjects (18 ARSACS patients; 18 controls) using three body‐worn sensors (Opal, APDM) in laboratory settings and free walking in public spaces. Sensor gait measures were analyzed for discriminative validity from controls, and for convergent (ie, clinical and patient relevance) validity by correlations with SPRS mobility (primary outcome) and Scale for the Assessment and Rating of Ataxia (SARA), Spastic Paraplegia Rating Scale (SPRS), and activities of daily living subscore of the Friedreich Ataxia Rating Scale (FARS‐ADL) (exploratory outcomes).

Results

Of 30 hypothesis‐based digital gait measures, 14 measures discriminated ARSACS patients from controls with large effect sizes (|Cliff's δ| > 0.8) in laboratory settings, with strongest discrimination by measures of spatiotemporal variability Lateral Step Deviation (δ = 0.98), SPcmp (δ = 0.94), and Swing CV (δ = 0.93). Large correlations with the SPRS mobility were observed for Swing CV (Spearman's ρ = 0.84), Speed (ρ = −0.63), and Harmonic Ratio V (ρ = −0.62). During supervised free walking in a public space, 11/30 gait measures discriminated ARSACS from controls with large effect sizes. Large correlations with SPRS mobility were here observed for Swing CV (ρ = 0.78) and Speed (ρ = −0.69), without reductions in effect sizes compared with laboratory settings.

Conclusions

We identified a promising set of digital‐motor candidate gait outcomes for ARSACS, applicable in multicenter settings, correlating with patient‐relevant health aspects, and with high validity also outside laboratory settings, thus simulating real‐life walking with higher ecological validity. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinocerebellar AtaxiasMuscle SpasticityHumansMaleFemaleAdultCross-Sectional StudiesMiddle AgedYoung AdultGaitGait Disorders, NeurologicAdolescentActivities of Daily LivingWalkingWearable Electronic Devices

Stichwörter der Autor:innen

ARSACSdigital gait outcomesoutcome measuresspastic ataxiawearable sensors

Autor:innen und Institutionen

  • Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center for Neurology, University of Tübingen, Tübingen, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.
  • Section Computational Sensomotorics, Hertie Institute for Clinical Brain Research, Tübingen, Germany.
  • Centre for Integrative Neuroscience (CIN), Tübingen, Germany.
  • Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center for Neurology, University of Tübingen, Tübingen, Germany.
  • Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy.

ORCID-Profile: Lukas Beichert, Winfried Ilg, Andreas Traschütz, Ayşe Nazli Başak, Cynthia Gagnon, Matthis Synofzik

Förderung

  • Deutsche Forschungsgemeinschaft
  • Else Kröner-Fresenius-Stiftung
  • Medizinischen Fakultät, Eberhard Karls Universität Tübingen
  • Ministero della Salute

Zitieren

APA

Beichert, L., Ilg, W., Kessler, C., Traschütz, A., Reich, S., Santorelli, F. M., Başak, A. N., Gagnon, C., PROSPAX Consortium, Schüle, R., & Synofzik, M. (2024). Digital Gait Outcomes for Autosomal Recessive Spastic Ataxia of Charlevoix‐Saguenay ( ARSACS) : Discriminative, Convergent, and Ecological Validity in a Multicenter Study ( PROSPAX ). Movement Disorders, 39(9), 1544-1555. https://doi.org/10.1002/mds.29876

Vancouver

Beichert L, Ilg W, Kessler C, Traschütz A, Reich S, Santorelli FM, et al. Digital Gait Outcomes for Autosomal Recessive Spastic Ataxia of Charlevoix‐Saguenay ( ARSACS) : Discriminative, Convergent, and Ecological Validity in a Multicenter Study ( PROSPAX ). Movement Disorders. 2024;39(9):1544-1555. doi:10.1002/mds.29876

BibTeX
@article{Beichert2024,
  author = {Beichert, Lukas and Ilg, Winfried and Kessler, Christoph and Traschütz, Andreas and Reich, Selina and Santorelli, Filippo M and Başak, Ayşe Nazli and Gagnon, Cynthia and PROSPAX Consortium, PROSPAX Consortium and Schüle, Rebecca and Synofzik, Matthis},
  title = {Digital Gait Outcomes for Autosomal Recessive Spastic Ataxia of Charlevoix‐Saguenay ( ARSACS) : Discriminative, Convergent, and Ecological Validity in a Multicenter Study ( PROSPAX )},
  journal = {Movement Disorders},
  year = {2024},
  volume = {39},
  number = {9},
  pages = {1544--1555},
  doi = {10.1002/mds.29876}
}
Kostenlos starten →